Abcellera Biologics Inc (NASDAQ:ABCL)
| 7.07 BATS BZX Real-Time Price As of 9:44am ET |  +0.16 / +2.32%Today’s Change | 5.53 Today|||52-Week Range 14.97 | -30.21% Year-to-Date |
Latest ABCL News | Press Releases
No recent news for Abcellera Biologics Inc.
Today’s Trading
| Previous close | 6.91 |
| Today’s open | 7.03 |
| Day’s range | 6.95 - 7.21 |
| Volume | 4,088 |
| Average volume (3 months) | 1,996,093 |
| Market cap | $2.0B |
Data as of 9:44am ET, 06/07/2023
Growth & Valuation
| Earnings growth (last year) | -0.07% |
| Earnings growth (this year) | -215.20% |
| Earnings growth (next 5 years) | -4.00% |
| Revenue growth (last year) | +29.38% |
| P/E ratio | NM |
| Price/Sales | 6.57 |
| Price/Book | 1.58 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | August 9, 2023 |
| EPS forecast (this quarter) | -$0.13 |
| Annual revenue (last year) | $485.4M |
| Annual profit (last year) | $158.5M |
| Net profit margin | 32.66% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |
Forecasts
